CA
BIOA

Cliff Asness’s BioAge Labs BIOA Stock Holding History

Cliff Asness’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
51,188
-18,146
-26% -$328K ﹤0.01% 2878
2026
Q1 		$1.21M Buy
69,334
+17,416
+34% +$335K ﹤0.01% 2662
2025
Q4 		$687K Buy
51,918
+16,172
+45% +$143K ﹤0.01% 2755
2025
Q3 		$210K Buy
35,746
+4,194
+13% +$19.6K ﹤0.01% 3236
2025
Q2 		$130K Buy
+31,552
New +$127K ﹤0.01% 3134

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Cliff Asness's BIOA Position: Q2 2026 in Review

Cliff Asness reduced its BioAge Labs (BIOA) stake by 26% in Q2 2026, selling an estimated $328K and leaving 51,188 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2878.

Cliff Asness first reported a position in BIOA in Q2 2025 and has held it in 5 quarters since. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Cliff Asness held 51,188 shares of BioAge Labs worth $1.25M as of Q2 2026.
  • Cliff Asness sold 18,146 BioAge Labs shares in Q2 2026, an estimated $328K.
  • BioAge Labs made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2878 holding.
  • Cliff Asness first reported a position in BioAge Labs in Q2 2025 and has held it in 5 quarters since.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.